Healthcare provider profile · identity verified

John Thomas Mcadory, M.D.

Family Practice · MIAMI, FL · NPI 1104800283

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	630	186
Amlodipine Besylate	Amlodipine Besylate	424	125
Losartan Potassium	Losartan Potassium	420	129
Hydrochlorothiazide	Hydrochlorothiazide	295	95
Metformin Hcl	Metformin Hcl	251	79
Lisinopril	Lisinopril	206	65
Pantoprazole Sodium	Pantoprazole Sodium	196	61
Simvastatin	Simvastatin	174	51
Tamsulosin Hcl	Tamsulosin Hcl	144	50
Diclofenac Sodium	Diclofenac Sodium	140	51
Levothyroxine Sodium	Levothyroxine Sodium	140	45
Metoprolol Tartrate	Metoprolol Tartrate	139	45
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	125	34
Temazepam	Temazepam	125	24
Albuterol Sulfate Hfa	Albuterol Sulfate	124	38
Eliquis	Apixaban	120	39
Metoprolol Succinate	Metoprolol Succinate	119	40
Omeprazole	Omeprazole	118	38
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	118	20
Sildenafil Citrate	Sildenafil Citrate	117	19
Allopurinol	Allopurinol	110	35
Methylprednisolone	Methylprednisolone	109	73
Naproxen	Naproxen	109	38
Ibuprofen	Ibuprofen	103	32
Gabapentin	Gabapentin	98	42
Rosuvastatin Calcium	Rosuvastatin Calcium	98	36
Glipizide	Glipizide	96	32
Tramadol Hcl	Tramadol Hcl	95	32
Carvedilol	Carvedilol	91	30
Triamcinolone Acetonide	Triamcinolone Acetonide	90	43
Montelukast Sodium	Montelukast Sodium	87	26
Nifedipine Er	Nifedipine	84	28
Azithromycin	Azithromycin	83	70
Jardiance	Empagliflozin	83	28
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	82	22
Fluticasone Propionate	Fluticasone Propionate	80	27
Spironolactone	Spironolactone	78	25
Meloxicam	Meloxicam	72	20
Clopidogrel	Clopidogrel Bisulfate	69	23
Symbicort	Budesonide/Formoterol Fumarate	67	22
Furosemide	Furosemide	64	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	62	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	62	17
Atenolol	Atenolol	60	20
Famotidine	Famotidine	60	19
Mirtazapine	Mirtazapine	59	18
Alprazolam	Alprazolam	58	12
Hydralazine Hcl	Hydralazine Hcl	57	21
Prednisone	Prednisone	54	22
Amoxicillin	Amoxicillin	53	32
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	53	21
Oxybutynin Chloride Er	Oxybutynin Chloride	52	21
Ozempic	Semaglutide	52	14
Nystatin	Nystatin	44	24
Potassium Chloride	Potassium Chloride	44	17
Finasteride	Finasteride	42	11
Clonidine Hcl	Clonidine Hcl	39	suppressed
Lorazepam	Lorazepam	38	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	37	33
Meclizine Hcl	Meclizine Hcl	37	19
Mounjaro	Tirzepatide	37	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	11
Acetaminophen-Codeine	Acetaminophen With Codeine	35	12
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	35	suppressed
Farxiga	Dapagliflozin Propanediol	35	17
Duloxetine Hcl	Duloxetine Hcl	33	12
Oxybutynin Chloride	Oxybutynin Chloride	33	suppressed
Linzess	Linaclotide	32	suppressed
Colchicine	Colchicine	31	11
Ezetimibe	Ezetimibe	31	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	31	suppressed
Bumetanide	Bumetanide	30	13
Clonazepam	Clonazepam	29	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	28	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	28	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	28	suppressed
Myrbetriq	Mirabegron	28	suppressed
Entresto	Sacubitril/Valsartan	27	suppressed
Fluconazole	Fluconazole	27	14
Diazepam	Diazepam	26	suppressed
Telmisartan	Telmisartan	26	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	26	suppressed
Glipizide Er	Glipizide	25	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Latanoprost	Latanoprost	23	suppressed
Baclofen	Baclofen	22	suppressed
Trazodone Hcl	Trazodone Hcl	22	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	21	suppressed
Ramipril	Ramipril	21	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	20
Tresiba Flextouch U-200	Insulin Degludec	21	suppressed
Valsartan	Valsartan	21	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Lactulose	Lactulose	20	11
Wixela Inhub	Fluticasone Propion/Salmeterol	20	suppressed
Breo Ellipta	Fluticasone/Vilanterol	19	suppressed
Alendronate Sodium	Alendronate Sodium	18	suppressed
Ipratropium Bromide	Ipratropium Bromide	18	suppressed
Lumigan	Bimatoprost	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Pravastatin Sodium	Pravastatin Sodium	17	suppressed
Breyna	Budesonide/Formoterol Fumarate	16	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	16	suppressed
Mupirocin	Mupirocin	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Novolog	Insulin Aspart	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Gemfibrozil	Gemfibrozil	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Isosorbide Mononitrate	Isosorbide Mononitrate	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Metformin Hcl Er	Metformin Hcl	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Metoprolol-Hydrochlorothiazide	Metoprolol/Hydrochlorothiazide	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Sertraline Hcl	Sertraline Hcl	13	suppressed
Droplet Insulin Syringe	Syrge-Ndl,ins 0.5 Ml Half Mark	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error